![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Holstein Andreas Stege Helger Kovacs Peter
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.9, Iss.2, 2010-03, pp. : 225-231
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Insulin aspart/insulin glargine: Localised lipoatrophy: case report
Reactions Weekly, Vol. 1, Iss. 1347, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Insulin analogues: Lipoatrophy in paediatric patients: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1339, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Insulin lispro: Lipoatrophy: case report
Reactions Weekly, Vol. 1, Iss. 1016, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Insulin lispro: Lipoatrophy: case report
Reactions Weekly, Vol. 1, Iss. 1393, 2012-01 ,pp. :